Novo Holdings, the controlling shareholder of Novo Nordisk, will invest in hospital chain Manipal Hospitals, as it seeks to tap into growing market potential in Asia. The investment would fill the gap between the demand and underserved healthcare infrastructure in India. It constitutes Novo Holding's largest investment in Asia to date.
Novo Holdings wil be part of the next phase of the journey of the provider of high-quality patient services. This gains importance on account of appreciation for advanced medical facilities and quality healthcare services driving an uptick in demand for private hospital care in the countryas well as expansion of health insurance coverage and medical technology adopted at private institutions. Manipal Hospitals has 33 hospitals across India, with around six million patients annually.
The Danish holding company invests in life science companies and had assets of 108 billion euros (USD 115.86 billion) at the end of 2022. It plans more hiring, open more offices and expand its geographic presence. Novo Holdings is the controlling shareholder of Novo Nordisk and Novozymes, and manages an investment portfolio with long-term return objective.
